NovaBay Pharmaceuticals Inc (NBY) financials · $51.9M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
NovaBay Pharmaceuticals Inc (NBY) $51.9M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | $9.78M |
| Cost of Revenue | N/A | $3.30M |
| Gross Profit | N/A | $6.48M |
| Operating Income | -$8.44M | -$5.84M |
| Net Income | -$22.1M | -$7.22M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $9.04M | $3.42M |
| Current Assets | $8.68M | $1.94M |
| Cash & Equivalents | $7.96M | $430.0K |
| Inventory | N/A | $765.0K |
| PP&E | N/A | $53.0K |
| Total Liabilities | $31.9M | $3.55M |
| Current Liabilities | $1.14M | $2.84M |
| Shareholders' Equity | -$23.2M | -$129.0K |
| Retained Earnings | -$210.4M | -$183.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$8.43M | -$7.50M |
| CapEx | N/A | $6.00K |
| Investing Cash Flow | N/A | $1.06M |
| Financing Cash Flow | $4.62M | $1.50M |
| Dividends Paid | $4.82M | $0 |
| Net Change in Cash | $7.32M | -$2.70M |
| Free Cash Flow | N/A | -$7.50M |
FAQ
What is NBY P/E and revenue?
NovaBay Pharmaceuticals Inc (NBY) $51.9M cap.
What is NBY revenue?
NBY income-statement cache has no revenue figure yet.
Is NBY profitable?
NovaBay Pharmaceuticals Inc last cached net income is -$22.1M (FY2025).
What are NBY total assets?
NovaBay Pharmaceuticals Inc last cached total assets are $9.04M (FY2025).
What is NBY free cash flow?
No cached cash-flow row for NBY yet.
Not investment advice. Cached statements, not a live tape.